Certainly is Oz.
The next inflection point is likely to be the disclosure of results from the onCARlytics JV with IMU. Will be either the conference presentation of in-vitro results or more importantly the results of in-vivo mouse trials.
As an aside, and without cross promoting, the recent acquisition by IMU of the CAR-T platform is almost certainly based upon successful results of the onCARlytics and CAR-T19 cancer killer trials. Haven't ever had any IMU shares but if they form a base (prior to release of the results) might be worth a look.
Breakout Looming?, page-16
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.7M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $34.18K | 285.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 974423 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 417920 | 7 |
View Market Depth
| Last trade - 10.41am 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
12.5¢ |
Change
0.000 ( 13.6 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.5¢ | 12.0¢ | 386518 | ||
| Last updated 10.56am 05/06/2024 ? | |||||
| ALA (ASX) Chart |